Current status and future perspectives on the Internet of Things in oncology

Hematology/Oncology and Stem Cell Therapy - 2021
Ibrahim N. Muhsen1, Omar W. Rasheed2, Eiad A. Habib2, Rakan K. Alsaad2, Mohannad K. Maghrabi2, Md A. Rahman3, Douglas Sicker4, William A. Wood5, Muhammad S. Beg6, Anthony D. Sung7, Shahrukh K. Hashmi8,9
1Department of Medicine, Houston Methodist Hospital, Houston, TX, USA
2College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
3Department of Cyber Security and Forensic Computing, University of Prince Mugrin, Medina, Saudi Arabia
4School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, USA
5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
6Division of Hematology/Medical Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA
7Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, NC, USA
8Division of Hematology, Department of Medicine Mayo Clinic, Rochester, MN, USA
9Department of Medicine, Sheikh Shakbout Medical City, Abu Dhabi, United Arab Emirates

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Hematology/Oncology and Stem Cell Therapy

Thông tin tác giả